GlaxoSmithKline GSK
$50.33 −$0.08 (-0.16%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $50.33 0.00%
Open$49.07
Prev close$50.41
Day range$48.94 – $50.74
Volume3.19M
Market cap$100.88B
P/E (TTM)17.5
Dividend yield3.56%
Analyst view
ConsensusHold
Analysts1
Average target$55.90+11.1% vs. price
- Hold 100%
Recent rating changes
The last 11 actions on file set price targets from $23.46 to $70.00, averaging $59.34.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 28 Oct 2026 | Jefferies | HOLD | $55.90 |
| 3 Aug 2026 | TD Cowen | HOLD | $70.00 |
| 11 Jun 2026 | TD Cowen | HOLD | $70.00 |
| 8 Jun 2026 | Argus Research | BUY | – |
| 29 May 2026 | TD Cowen | HOLD | $70.00 |
| 29 May 2026 | Jefferies | BUY | $67.10 |
| 9 Feb 2026 | TD Cowen | HOLD | $70.00 |
| 7 Jan 2026 | Jefferies | BUY | $55.60 |
| 6 Jan 2026 | Barclays | SELL | – |
| 18 Dec 2025 | TD Cowen | HOLD | $52.00 |
| 29 Oct 2025 | BofA Securities | SELL | $23.46 |
No comments yet — be the first to weigh in on GSK.
Sign in to join the discussion.